novartis

Latest news and analysis on novartis

Equities

What the market is missing on this “pioneering” global pharma company

Impressive cash flow underpinned by diversified in-market assets and an underappreciated mid-stage pipeline is just part of the appeal of the global healthcare company...
Magellan Investment Partners
Magellan Investment Partners
Equities

Reimagining medicine: Novartis’ breakthrough therapies

With a market cap of more than $200 billion, Novartis is one of the largest pharmaceutical companies in the world and a leader in developing trusted innovative...
Magellan Investment Partners
Magellan Investment Partners

The world's largest sovereign wealth fund: A closer look. In a move to increase transparency and strengthen the vote execution chain, the world's largest...

Saxo Capital Markets Australia
Saxo Capital Markets Australia
Multi-asset trading platform
3